China's WuXi Biologics is to sell its vaccine manufacturing site in Dundalk to MSD Ireland in a €500m deal. The acquisition is expected to be completed in the first half of this year and will ...
The employees at WuXi Biologics have once again shown their commitment to the local community with their fourth annual Christmas appeal for the St. Vincent de Paul Society in Dundalk. Continuing their ...
The pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility ...
Merck's €500 million investment in Dundalk adds to €3 billion invested in Ireland over three years. Approximately 1,000 new jobs planned, including 150 at the Dundalk facility. The $520.1 ...
WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025, the ...
Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its long-term plans in Ireland. MSD said the deal is worth €500m and ...
Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 ...
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...
The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside of China The MSD site in Dundalk, Co Louth. The Dundalk site will ...
The employees at WuXi Biologics have once again shown their commitment to the local community with their fourth annual Christmas appeal for the St. Vincent de Paul Society in Dundalk. Continuing ...
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese company seeks to enhance its margins while continuing to navigate ...